Specify a stock or a cryptocurrency in the search bar to get a summary
Noevir Holdings Co Ltd
4928Noevir Holdings Co., Ltd. develops, produces, and sells cosmetics, pharmaceuticals, and health food products in Japan, China, Taiwan, South Korea, Hong Kong, Singapore, Thailand, the United States, and Canada. The company's Cosmetics segment develops, produces, and sells skincare products under various brands, including Noevir and Nameraka Honpo; excel make up line products and NOV hypoallergenic cosmetics, as well as provides contract manufacturing services for cosmetics and quasi drugs. Its Pharmaceutical & Health Food segment produces and sells Nanten Nodo Ame cough drops; functional drinks, such as the Min Min Da Ha; and over-the-counter pharmaceuticals comprising cold remedies, eye drops, and digestive aids, as well as nutritional supplements, and other products. The company's Other segment sells and leases apparel and aircrafts. The company also produces and sells toiletries; market research; and provides air transportation and training services. The company sells its products through drug stores and variety stores, and dermatology and medical institutions, as well as Noevir beauty studios and own retail stores. Noevir Holdings Co., Ltd. was founded in 1964 and is headquartered in Chuo, Japan. Address: 6-13-1 Minatojima-Nakamachi, Chuo, Japan, 650-8521
Analytics
WallStreet Target Price
821 062.41 JPYP/E ratio
21.3432Dividend Yield
4.86 %Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures 4928
Dividend Analytics 4928
Dividend growth over 5 years
22 %Continuous growth
3 yearsPayout Ratio 5 years average
99 %Dividend History 4928
Stock Valuation 4928
Financials 4928
Results | 2019 | Dynamics |